LEXINGTON, Mass.–(BUSINESS WIRE)–December 7, 2017–
Quanterix Company, an organization with a subsequent technology, ultra-sensitive virtual platform that advances precision well being, these days introduced the pricing of its preliminary public providing of four,275,200 stocks of its commonplace inventory at a public providing value of $15.00 according to percentage for combination gross proceeds of $64,128,00zero. As well as, Quanterix has granted the underwriters a 30-day choice to buy as much as 641,280 further stocks of commonplace inventory on the preliminary public providing value, much less the underwriting bargain. The stocks are scheduled to start buying and selling on The Nasdaq International Marketplace below the ticker image “QTRX” on December 7, 2017, and the providing is predicted to near on December 11, 2017, topic to standard ultimate prerequisites.
J.P. Morgan Securities LLC, Leerink Companions LLC and Cowen and Corporate, LLC are serving as joint book-running managers for the providing. BTIG, LLC and Evercore Crew L.L.C. are serving as co-managers.
A registration remark when it comes to those securities was once declared efficient via the Securities and Alternate Fee on December 6, 2017. The providing can be made most effective by the use of a prospectus. A replica of the ultimate prospectus associated with the providing can be filed with the Securities and Alternate Fee and is also got, when to be had, from J.P. Morgan Securities LLC, c/o Broadridge Monetary Answers, 1155 Lengthy Island Street, Edgewood, NY 11717, phone: (866) 803-9204; Leerink Companions LLC, Consideration: Syndicate Division, One Federal Boulevard, 37th Ground, Boston, MA 02110, via phone at (800) 808-7525, ext. 6132 or via electronic mail at firstname.lastname@example.org; or Cowen and Corporate, LLC, c/o Broadridge Monetary Answers, 1155 Lengthy Island Street, Edgewood, NY 11717, Attn: Prospectus Division, or via calling (631) 274-2806 or via faxing (631) 254-7140.
This press unlock shall no longer represent an be offering to promote or the solicitation of an be offering to shop for, nor shall there be any sale of, those securities in any state or jurisdiction by which such be offering, solicitation or sale could be illegal previous to registration or qualification of those securities below the securities regulations of this sort of state or jurisdiction.
Ahead-Taking a look Statements
This press unlock comprises sure forward-looking statements, together with statements in regards to Quanterix Company’s proposed preliminary public providing. Phrases akin to “expects,” “anticipates” and “intends” or identical expressions are supposed to spot forward-looking statements. Those forward-looking statements are topic to the inherent uncertainties in predicting long run effects and prerequisites and no assurance can also be for the reason that the preliminary public providing mentioned above can be finished at the phrases described. Crowning glory of the proposed preliminary public providing and the phrases thereof are topic to a lot of elements, a lot of which might be past the regulate of the Corporate, together with, with out limitation, failure of standard ultimate prerequisites and the chance elements and different issues set forth within the prospectus incorporated within the registration remark, within the shape remaining filed with the Fee. Quanterix undertakes no legal responsibility to publicly replace or revise any forward-looking statements, whether or not as a results of new data, long run occasions or differently, apart from as would possibly be required via legislation.
Quanterix is a corporation digitizing biomarker research with the purpose of advancing the science of precision well being. The corporate’s virtual well being answer, Simoa, has the possible to modify the way in which by which healthcare is equipped these days via giving researchers the talent to intently read about the continuum from well being to illness. Quanterix’ generation is designed to permit a lot previous illness detection, higher prognoses and enhanced remedy the right way to reinforce the standard of lifestyles and longevity of the inhabitants for generations to come. The generation is these days getting used for analysis programs in numerous healing spaces, together with oncology, neurology, cardiology, irritation and infectious illness. The corporate was once established in 2007 and is situated in Lexington, Massachusetts.
Quanterix PR Touch:
Lauren Kaufman, 617-502-4300
Quanterix IR Touch:
Joe Driscoll, 617-301-9400
Leader Monetary Officer